Daniel I Chasman, Franco Giulianini, Jean MacFadyen, Bryan J Barratt, Fredrik Nyberg, Paul M Ridker. Circ Cardiovasc Genet 2012
Times Cited: 190
Times Cited: 190
Times Cited
Times Co-cited
Similarity
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.
Iris Postmus, Stella Trompet, Harshal A Deshmukh, Michael R Barnes, Xiaohui Li, Helen R Warren, Daniel I Chasman, Kaixin Zhou, Benoit J Arsenault, Louise A Donnelly,[...]. Nat Commun 2014
Iris Postmus, Stella Trompet, Harshal A Deshmukh, Michael R Barnes, Xiaohui Li, Helen R Warren, Daniel I Chasman, Kaixin Zhou, Benoit J Arsenault, Louise A Donnelly,[...]. Nat Commun 2014
28
SLCO1B1 variants and statin-induced myopathy--a genomewide study.
E Link, S Parish, J Armitage, L Bowman, S Heath, F Matsuda, I Gut, M Lathrop, R Collins. N Engl J Med 2008
E Link, S Parish, J Armitage, L Bowman, S Heath, F Matsuda, I Gut, M Lathrop, R Collins. N Engl J Med 2008
26
Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a).
Harshal A Deshmukh, Helen M Colhoun, Toby Johnson, Paul M McKeigue, D John Betteridge, Paul N Durrington, John H Fuller, Shona Livingstone, Valentine Charlton-Menys, Andrew Neil,[...]. J Lipid Res 2012
Harshal A Deshmukh, Helen M Colhoun, Toby Johnson, Paul M McKeigue, D John Betteridge, Paul N Durrington, John H Fuller, Shona Livingstone, Valentine Charlton-Menys, Andrew Neil,[...]. J Lipid Res 2012
25
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.
Jemma C Hopewell, Sarah Parish, Alison Offer, Emma Link, Robert Clarke, Mark Lathrop, Jane Armitage, Rory Collins. Eur Heart J 2013
Jemma C Hopewell, Sarah Parish, Alison Offer, Emma Link, Robert Clarke, Mark Lathrop, Jane Armitage, Rory Collins. Eur Heart J 2013
25
Genome-wide association of lipid-lowering response to statins in combined study populations.
Mathew J Barber, Lara M Mangravite, Craig L Hyde, Daniel I Chasman, Joshua D Smith, Catherine A McCarty, Xiaohui Li, Russell A Wilke, Mark J Rieder, Paul T Williams,[...]. PLoS One 2010
Mathew J Barber, Lara M Mangravite, Craig L Hyde, Daniel I Chasman, Joshua D Smith, Catherine A McCarty, Xiaohui Li, Russell A Wilke, Mark J Rieder, Paul T Williams,[...]. PLoS One 2010
17
Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort.
John F Thompson, Craig L Hyde, Linda S Wood, Sara A Paciga, David A Hinds, David R Cox, G Kees Hovingh, John J P Kastelein. Circ Cardiovasc Genet 2009
John F Thompson, Craig L Hyde, Linda S Wood, Sara A Paciga, David A Hinds, David R Cox, G Kees Hovingh, John J P Kastelein. Circ Cardiovasc Genet 2009
17
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
C Baigent, L Blackwell, J Emberson, L E Holland, C Reith, N Bhala, R Peto, E H Barnes, A Keech, J Simes,[...]. Lancet 2010
C Baigent, L Blackwell, J Emberson, L E Holland, C Reith, N Bhala, R Peto, E H Barnes, A Keech, J Simes,[...]. Lancet 2010
17
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Paul M Ridker, Eleanor Danielson, Francisco A H Fonseca, Jacques Genest, Antonio M Gotto, John J P Kastelein, Wolfgang Koenig, Peter Libby, Alberto J Lorenzatti, Jean G MacFadyen,[...]. N Engl J Med 2008
Paul M Ridker, Eleanor Danielson, Francisco A H Fonseca, Jacques Genest, Antonio M Gotto, John J P Kastelein, Wolfgang Koenig, Peter Libby, Alberto J Lorenzatti, Jean G MacFadyen,[...]. N Engl J Med 2008
16
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Marc S Sabatine, Robert P Giugliano, Anthony C Keech, Narimon Honarpour, Stephen D Wiviott, Sabina A Murphy, Julia F Kuder, Huei Wang, Thomas Liu, Scott M Wasserman,[...]. N Engl J Med 2017
Marc S Sabatine, Robert P Giugliano, Anthony C Keech, Narimon Honarpour, Stephen D Wiviott, Sabina A Murphy, Julia F Kuder, Huei Wang, Thomas Liu, Scott M Wasserman,[...]. N Engl J Med 2017
16
Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients.
Hon-Kit Lee, Miao Hu, Sandra Sh Lui, Chung-Shun Ho, Chun-Kwok Wong, Brian Tomlinson. Pharmacogenomics 2013
Hon-Kit Lee, Miao Hu, Sandra Sh Lui, Chung-Shun Ho, Chun-Kwok Wong, Brian Tomlinson. Pharmacogenomics 2013
19
Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
Erik S Stroes, Paul D Thompson, Alberto Corsini, Georgirene D Vladutiu, Frederick J Raal, Kausik K Ray, Michael Roden, Evan Stein, Lale Tokgözoğlu, Børge G Nordestgaard,[...]. Eur Heart J 2015
Erik S Stroes, Paul D Thompson, Alberto Corsini, Georgirene D Vladutiu, Frederick J Raal, Kausik K Ray, Michael Roden, Evan Stein, Lale Tokgözoğlu, Børge G Nordestgaard,[...]. Eur Heart J 2015
15
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
C Baigent, A Keech, P M Kearney, L Blackwell, G Buck, C Pollicino, A Kirby, T Sourjina, R Peto, R Collins,[...]. Lancet 2005
C Baigent, A Keech, P M Kearney, L Blackwell, G Buck, C Pollicino, A Kirby, T Sourjina, R Peto, R Collins,[...]. Lancet 2005
14
The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.
L B Ramsey, S G Johnson, K E Caudle, C E Haidar, D Voora, R A Wilke, W D Maxwell, H L McLeod, R M Krauss, D M Roden,[...]. Clin Pharmacol Ther 2014
L B Ramsey, S G Johnson, K E Caudle, C E Haidar, D Voora, R A Wilke, W D Maxwell, H L McLeod, R M Krauss, D M Roden,[...]. Clin Pharmacol Ther 2014
13
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Christopher P Cannon, Michael A Blazing, Robert P Giugliano, Amy McCagg, Jennifer A White, Pierre Theroux, Harald Darius, Basil S Lewis, Ton Oude Ophuis, J Wouter Jukema,[...]. N Engl J Med 2015
Christopher P Cannon, Michael A Blazing, Robert P Giugliano, Amy McCagg, Jennifer A White, Pierre Theroux, Harald Darius, Basil S Lewis, Ton Oude Ophuis, J Wouter Jukema,[...]. N Engl J Med 2015
13
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.
Jennifer G Robinson, Michel Farnier, Michel Krempf, Jean Bergeron, Gérald Luc, Maurizio Averna, Erik S Stroes, Gisle Langslet, Frederick J Raal, Mahfouz El Shahawy,[...]. N Engl J Med 2015
Jennifer G Robinson, Michel Farnier, Michel Krempf, Jean Bergeron, Gérald Luc, Maurizio Averna, Erik S Stroes, Gisle Langslet, Frederick J Raal, Mahfouz El Shahawy,[...]. N Engl J Med 2015
13
ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin.
B Tomlinson, M Hu, V W Y Lee, S S H Lui, T T W Chu, E W M Poon, G T C Ko, L Baum, L S Tam, E K Li. Clin Pharmacol Ther 2010
B Tomlinson, M Hu, V W Y Lee, S S H Lui, T T W Chu, E W M Poon, G T C Ko, L Baum, L S Tam, E K Li. Clin Pharmacol Ther 2010
12
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
Jonathan C Cohen, Eric Boerwinkle, Thomas H Mosley, Helen H Hobbs. N Engl J Med 2006
Jonathan C Cohen, Eric Boerwinkle, Thomas H Mosley, Helen H Hobbs. N Engl J Med 2006
12
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Neil J Stone, Jennifer G Robinson, Alice H Lichtenstein, C Noel Bairey Merz, Conrad B Blum, Robert H Eckel, Anne C Goldberg, David Gordon, Daniel Levy, Donald M Lloyd-Jones,[...]. Circulation 2014
Neil J Stone, Jennifer G Robinson, Alice H Lichtenstein, C Noel Bairey Merz, Conrad B Blum, Robert H Eckel, Anne C Goldberg, David Gordon, Daniel Levy, Donald M Lloyd-Jones,[...]. Circulation 2014
12
Pharmacogenetic study of statin therapy and cholesterol reduction.
Daniel I Chasman, David Posada, Lakshman Subrahmanyan, Nancy R Cook, Vincent P Stanton, Paul M Ridker. JAMA 2004
Daniel I Chasman, David Posada, Lakshman Subrahmanyan, Nancy R Cook, Vincent P Stanton, Paul M Ridker. JAMA 2004
11
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
B Mihaylova, J Emberson, L Blackwell, A Keech, J Simes, E H Barnes, M Voysey, A Gray, R Collins, C Baigent. Lancet 2012
B Mihaylova, J Emberson, L Blackwell, A Keech, J Simes, E H Barnes, M Voysey, A Gray, R Collins, C Baigent. Lancet 2012
11
Discovery and refinement of loci associated with lipid levels.
Cristen J Willer, Ellen M Schmidt, Sebanti Sengupta, Gina M Peloso, Stefan Gustafsson, Stavroula Kanoni, Andrea Ganna, Jin Chen, Martin L Buchkovich, Samia Mora,[...]. Nat Genet 2013
Cristen J Willer, Ellen M Schmidt, Sebanti Sengupta, Gina M Peloso, Stefan Gustafsson, Stavroula Kanoni, Andrea Ganna, Jin Chen, Martin L Buchkovich, Samia Mora,[...]. Nat Genet 2013
11
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.
Alberico L Catapano, Ian Graham, Guy De Backer, Olov Wiklund, M John Chapman, Heinz Drexel, Arno W Hoes, Catriona S Jennings, Ulf Landmesser, Terje R Pedersen,[...]. Eur Heart J 2016
Alberico L Catapano, Ian Graham, Guy De Backer, Olov Wiklund, M John Chapman, Heinz Drexel, Arno W Hoes, Catriona S Jennings, Ulf Landmesser, Terje R Pedersen,[...]. Eur Heart J 2016
11
ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin.
J E Keskitalo, O Zolk, M F Fromm, K J Kurkinen, P J Neuvonen, M Niemi. Clin Pharmacol Ther 2009
J E Keskitalo, O Zolk, M F Fromm, K J Kurkinen, P J Neuvonen, M Niemi. Clin Pharmacol Ther 2009
10
Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care.
Marianne K DeGorter, Rommel G Tirona, Ute I Schwarz, Yun-Hee Choi, George K Dresser, Neville Suskin, Kathryn Myers, GuangYong Zou, Otito Iwuchukwu, Wei-Qi Wei,[...]. Circ Cardiovasc Genet 2013
Marianne K DeGorter, Rommel G Tirona, Ute I Schwarz, Yun-Hee Choi, George K Dresser, Neville Suskin, Kathryn Myers, GuangYong Zou, Otito Iwuchukwu, Wei-Qi Wei,[...]. Circ Cardiovasc Genet 2013
10
A global reference for human genetic variation.
Adam Auton, Lisa D Brooks, Richard M Durbin, Erik P Garrison, Hyun Min Kang, Jan O Korbel, Jonathan L Marchini, Shane McCarthy, Gil A McVean, Gonçalo R Abecasis. Nature 2015
Adam Auton, Lisa D Brooks, Richard M Durbin, Erik P Garrison, Hyun Min Kang, Jan O Korbel, Jonathan L Marchini, Shane McCarthy, Gil A McVean, Gonçalo R Abecasis. Nature 2015
10
Principal components analysis corrects for stratification in genome-wide association studies.
Alkes L Price, Nick J Patterson, Robert M Plenge, Michael E Weinblatt, Nancy A Shadick, David Reich. Nat Genet 2006
Alkes L Price, Nick J Patterson, Robert M Plenge, Michael E Weinblatt, Nancy A Shadick, David Reich. Nat Genet 2006
9
Clinical implications of pharmacogenomics of statin treatment.
L M Mangravite, C F Thorn, R M Krauss. Pharmacogenomics J 2006
L M Mangravite, C F Thorn, R M Krauss. Pharmacogenomics J 2006
9
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Shaun Purcell, Benjamin Neale, Kathe Todd-Brown, Lori Thomas, Manuel A R Ferreira, David Bender, Julian Maller, Pamela Sklar, Paul I W de Bakker, Mark J Daly,[...]. Am J Hum Genet 2007
Shaun Purcell, Benjamin Neale, Kathe Todd-Brown, Lori Thomas, Manuel A R Ferreira, David Bender, Julian Maller, Pamela Sklar, Paul I W de Bakker, Mark J Daly,[...]. Am J Hum Genet 2007
9
A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.
Majid Nikpay, Anuj Goel, Hong-Hee Won, Leanne M Hall, Christina Willenborg, Stavroula Kanoni, Danish Saleheen, Theodosios Kyriakou, Christopher P Nelson, Jemma C Hopewell,[...]. Nat Genet 2015
Majid Nikpay, Anuj Goel, Hong-Hee Won, Leanne M Hall, Christina Willenborg, Stavroula Kanoni, Danish Saleheen, Theodosios Kyriakou, Christopher P Nelson, Jemma C Hopewell,[...]. Nat Genet 2015
9
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
Børge G Nordestgaard, M John Chapman, Steve E Humphries, Henry N Ginsberg, Luis Masana, Olivier S Descamps, Olov Wiklund, Robert A Hegele, Frederick J Raal, Joep C Defesche,[...]. Eur Heart J 2013
Børge G Nordestgaard, M John Chapman, Steve E Humphries, Henry N Ginsberg, Luis Masana, Olivier S Descamps, Olov Wiklund, Robert A Hegele, Frederick J Raal, Joep C Defesche,[...]. Eur Heart J 2013
9
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.
Daniel I Swerdlow, David Preiss, Karoline B Kuchenbaecker, Michael V Holmes, Jorgen E L Engmann, Tina Shah, Reecha Sofat, Stefan Stender, Paul C D Johnson, Robert A Scott,[...]. Lancet 2015
Daniel I Swerdlow, David Preiss, Karoline B Kuchenbaecker, Michael V Holmes, Jorgen E L Engmann, Tina Shah, Reecha Sofat, Stefan Stender, Paul C D Johnson, Robert A Scott,[...]. Lancet 2015
9
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.
Marianne Abifadel, Mathilde Varret, Jean-Pierre Rabès, Delphine Allard, Khadija Ouguerram, Martine Devillers, Corinne Cruaud, Suzanne Benjannet, Louise Wickham, Danièle Erlich,[...]. Nat Genet 2003
Marianne Abifadel, Mathilde Varret, Jean-Pierre Rabès, Delphine Allard, Khadija Ouguerram, Martine Devillers, Corinne Cruaud, Suzanne Benjannet, Louise Wickham, Danièle Erlich,[...]. Nat Genet 2003
9
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.
Marc S Sabatine, Robert P Giugliano, Stephen D Wiviott, Frederick J Raal, Dirk J Blom, Jennifer Robinson, Christie M Ballantyne, Ransi Somaratne, Jason Legg, Scott M Wasserman,[...]. N Engl J Med 2015
Marc S Sabatine, Robert P Giugliano, Stephen D Wiviott, Frederick J Raal, Dirk J Blom, Jennifer Robinson, Christie M Ballantyne, Ransi Somaratne, Jason Legg, Scott M Wasserman,[...]. N Engl J Med 2015
9
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.
Naveed Sattar, David Preiss, Heather M Murray, Paul Welsh, Brendan M Buckley, Anton J M de Craen, Sreenivasa Rao Kondapally Seshasai, John J McMurray, Dilys J Freeman, J Wouter Jukema,[...]. Lancet 2010
Naveed Sattar, David Preiss, Heather M Murray, Paul Welsh, Brendan M Buckley, Anton J M de Craen, Sreenivasa Rao Kondapally Seshasai, John J McMurray, Dilys J Freeman, J Wouter Jukema,[...]. Lancet 2010
9
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
François Mach, Colin Baigent, Alberico L Catapano, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference,[...]. Eur Heart J 2020
François Mach, Colin Baigent, Alberico L Catapano, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference,[...]. Eur Heart J 2020
9
Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 Study.
Kristian M Bailey, Simon P R Romaine, Beryl M Jackson, Amanda J Farrin, Maria Efthymiou, Julian H Barth, Joanne Copeland, Terry McCormack, Andrew Whitehead, Marcus D Flather,[...]. Circ Cardiovasc Genet 2010
Kristian M Bailey, Simon P R Romaine, Beryl M Jackson, Amanda J Farrin, Maria Efthymiou, Julian H Barth, Joanne Copeland, Terry McCormack, Andrew Whitehead, Marcus D Flather,[...]. Circ Cardiovasc Genet 2010
11
Identification of genetic variants associated with response to statin therapy.
Jessica L Mega, David A Morrow, Alison Brown, Christopher P Cannon, Marc S Sabatine. Arterioscler Thromb Vasc Biol 2009
Jessica L Mega, David A Morrow, Alison Brown, Christopher P Cannon, Marc S Sabatine. Arterioscler Thromb Vasc Biol 2009
13
Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients.
Miao Hu, Sandra S H Lui, Valiant W L Mak, Tanya T W Chu, Vivian W Y Lee, Emily W M Poon, Teresa K C Tsui, Gary T C Ko, Larry Baum, Lai-Shan Tam,[...]. Pharmacogenet Genomics 2010
Miao Hu, Sandra S H Lui, Valiant W L Mak, Tanya T W Chu, Vivian W Y Lee, Emily W M Poon, Teresa K C Tsui, Gary T C Ko, Larry Baum, Lai-Shan Tam,[...]. Pharmacogenet Genomics 2010
22
The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment.
Marilu Fiegenbaum, Fabiano R da Silveira, Cézar R Van der Sand, Luiz Carlos Van der Sand, Maria E W Ferreira, Renan C Pires, Mara H Hutz. Clin Pharmacol Ther 2005
Marilu Fiegenbaum, Fabiano R da Silveira, Cézar R Van der Sand, Luiz Carlos Van der Sand, Maria E W Ferreira, Renan C Pires, Mara H Hutz. Clin Pharmacol Ther 2005
8
A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.
Fumihiko Takeuchi, Ralph McGinnis, Stephane Bourgeois, Chris Barnes, Niclas Eriksson, Nicole Soranzo, Pamela Whittaker, Venkatesh Ranganath, Vasudev Kumanduri, William McLaren,[...]. PLoS Genet 2009
Fumihiko Takeuchi, Ralph McGinnis, Stephane Bourgeois, Chris Barnes, Niclas Eriksson, Nicole Soranzo, Pamela Whittaker, Venkatesh Ranganath, Vasudev Kumanduri, William McLaren,[...]. PLoS Genet 2009
8
Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?
Bruce K Birmingham, Sarah R Bujac, Robert Elsby, Connie T Azumaya, Cheryl Wei, Yusong Chen, Rogelio Mosqueda-Garcia, Helen J Ambrose. Eur J Clin Pharmacol 2015
Bruce K Birmingham, Sarah R Bujac, Robert Elsby, Connie T Azumaya, Cheryl Wei, Yusong Chen, Rogelio Mosqueda-Garcia, Helen J Ambrose. Eur J Clin Pharmacol 2015
9
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.
S Matthijs Boekholdt, G Kees Hovingh, Samia Mora, Benoit J Arsenault, Pierre Amarenco, Terje R Pedersen, John C LaRosa, David D Waters, David A DeMicco, R John Simes,[...]. J Am Coll Cardiol 2014
S Matthijs Boekholdt, G Kees Hovingh, Samia Mora, Benoit J Arsenault, Pierre Amarenco, Terje R Pedersen, John C LaRosa, David D Waters, David A DeMicco, R John Simes,[...]. J Am Coll Cardiol 2014
8
Statins for the primary prevention of cardiovascular disease.
Fiona Taylor, Mark D Huffman, Ana Filipa Macedo, Theresa H M Moore, Margaret Burke, George Davey Smith, Kirsten Ward, Shah Ebrahim. Cochrane Database Syst Rev 2013
Fiona Taylor, Mark D Huffman, Ana Filipa Macedo, Theresa H M Moore, Margaret Burke, George Davey Smith, Kirsten Ward, Shah Ebrahim. Cochrane Database Syst Rev 2013
8
The SLCO1B1*5 genetic variant is associated with statin-induced side effects.
Deepak Voora, Svati H Shah, Ivan Spasojevic, Shazia Ali, Carol R Reed, Benjamin A Salisbury, Geoffrey S Ginsburg. J Am Coll Cardiol 2009
Deepak Voora, Svati H Shah, Ivan Spasojevic, Shazia Ali, Carol R Reed, Benjamin A Salisbury, Geoffrey S Ginsburg. J Am Coll Cardiol 2009
8
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.
Marja K Pasanen, Mikko Neuvonen, Pertti J Neuvonen, Mikko Niemi. Pharmacogenet Genomics 2006
Marja K Pasanen, Mikko Neuvonen, Pertti J Neuvonen, Mikko Niemi. Pharmacogenet Genomics 2006
8
Seventeen years of statin pharmacogenetics: a systematic review.
Maarten Leusink, N Charlotte Onland-Moret, Paul I W de Bakker, Anthonius de Boer, Anke H Maitland-van der Zee. Pharmacogenomics 2016
Maarten Leusink, N Charlotte Onland-Moret, Paul I W de Bakker, Anthonius de Boer, Anke H Maitland-van der Zee. Pharmacogenomics 2016
24
Interpretation of the evidence for the efficacy and safety of statin therapy.
Rory Collins, Christina Reith, Jonathan Emberson, Jane Armitage, Colin Baigent, Lisa Blackwell, Roger Blumenthal, John Danesh, George Davey Smith, David DeMets,[...]. Lancet 2016
Rory Collins, Christina Reith, Jonathan Emberson, Jane Armitage, Colin Baigent, Lisa Blackwell, Roger Blumenthal, John Danesh, George Davey Smith, David DeMets,[...]. Lancet 2016
8
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.
Brian A Ference, Henry N Ginsberg, Ian Graham, Kausik K Ray, Chris J Packard, Eric Bruckert, Robert A Hegele, Ronald M Krauss, Frederick J Raal, Heribert Schunkert,[...]. Eur Heart J 2017
Brian A Ference, Henry N Ginsberg, Ian Graham, Kausik K Ray, Chris J Packard, Eric Bruckert, Robert A Hegele, Ronald M Krauss, Frederick J Raal, Heribert Schunkert,[...]. Eur Heart J 2017
8
Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment.
Ronald M Krauss, Lara M Mangravite, Joshua D Smith, Marisa W Medina, Dai Wang, Xiuqing Guo, Mark J Rieder, Joel A Simon, Steven B Hulley, David Waters,[...]. Circulation 2008
Ronald M Krauss, Lara M Mangravite, Joshua D Smith, Marisa W Medina, Dai Wang, Xiuqing Guo, Mark J Rieder, Joel A Simon, Steven B Hulley, David Waters,[...]. Circulation 2008
7
Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER.
Eliana Polisecki, Hind Muallem, Nobuyo Maeda, Inga Peter, Michele Robertson, Alex D McMahon, Ian Ford, Christopher Packard, James Shepherd, J Wouter Jukema,[...]. Atherosclerosis 2008
Eliana Polisecki, Hind Muallem, Nobuyo Maeda, Inga Peter, Michele Robertson, Alex D McMahon, Ian Ford, Christopher Packard, James Shepherd, J Wouter Jukema,[...]. Atherosclerosis 2008
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.